18F-FDG-PET/CT in the diagnosis of lymphadenopathy
Authors:
doc. MUDr. Řehák Zdeněk, Ph.D. 1; prof. MUDr. Adam Zdeněk, CSc. 2; doc. MUDr. Horváth Teodor, Ph.D. 3; MUDr. Vašina Jiří 1; MUDr. Koukalová Renata, Ph.D. 1; MUDr. Fabian Pavel, Ph.D. 4; Ing. et Ing. Jan Adam, Ph.D. 1,5
Authors‘ workplace:
Oddělení nukleární medicíny, MOÚ, Brno
1; Interní hematologická a onkologická klinika LF MU a FN Brno
2; Chirurgická klinika LF MU a FN Brno
3; Oddělení onkologické patologie, MOÚ, Brno
4; ÚJV Řež, a. s.
5
Published in:
Klin Onkol 2026; 39(4): 302-304
Category:
Oncology in Images
doi:
https://doi.org/10.48095/ccko2026302
Sources
1. Pacák J, Točík Z, Černý M. Synthesis of 2-deoxy-2-fluoro--D-glucose. J Chem Soc D 1969; 5 (2): 77. doi: 10.1039/ C29690000077.
2. Křivanová A, Adam Z, Mayer J et al. Teplota nejasné etiologie: příčiny a diagnostický postup. Vnitr Lek 2007; 53 (2): 169–178.
3. Jaruskova M, Belohlavek O. Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. Eur J Nucl Med Mol Imaging 2006; 33 (8): 913–918. doi: 10.1007/s00259-006-0064-z.
4. Vašina J, Bílek O, Řehák Z et al. Seminom a sarkoidóza – komplikace hodnocení léčebné odpovědi pomocí 18F-FDG PET/CT – kazuistika. Nukl Med 2014; 3 (1): 14–17.
5. Zeman MN, Green C, Akin EA. Spectrum of [18F]FDG--PET/CT findings in benign lymph node pathology. Mol Imaging Biol 2021; 23 (4): 469–480. doi: 10.1007/s11307-020-01576-8.
6. Ito K, Morooka M, Kubota K. Kikuchi disease: 18 F-FDG positron emission tomography/computed tomography of lymph node uptake. Jpn J Radiol 2010; 28 (1): 15–19. doi: 10.1007/s11604-009-0375-7.
7. Horváth T, Frola L, Adam Z et al. Léčba unicentrické Castlemanovy choroby rituximabem, bendamustinem a dexametazonem zmenšila objem neoperabilního expanzivního ložiska v horním mediastinu a umožnila jeho radikální odstranění. Klin Onkol 2025; 38 (2): 132–143. doi: 10.48095/ccko2025132.
8. Koukalová R, Selingerová I, Řehák Z et al. FDG-PET/ CT for initial staging and response assessment in Castleman disease – retrospective single-center study of 29 cases. Klin Onkol 2021; 34 (2): 120–127. doi: 10.48095/ccko2021120.
9. Szturz P, Adam Z, Rehak Z et al. Salvage lenalidomide in four rare oncological diseases. Tumori 2013; 99 (5): e251–e256. doi: 10.1177/030089161309900524.
10. Janikova A, Bolcak K, Pavlik T et al. Value of [18F] fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: the end of a dilemma? Clin Lymphoma Myeloma 2008; 8 (5): 287–293. doi: 10.3816/CLM.2008.n.040.
Labels
Paediatric clinical oncology Surgery Clinical oncologyArticle was published in
Clinical Oncology
2026 Issue 4
- Safety and Tolerance of Metamizole in Postoperative Analgesia in Children
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
- Obstacle Called Vasospasm: Which Solution Is Most Effective in Microsurgery and How to Pharmacologically Assist It?
- Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
Most read in this issue
- Treatment of Erdheim-Chester disease from the perspective in 2026
- Dlouhá cesta k RAS (on) inhibitoru
- IgG4-related disease – treatment with anti-CD20, anti-CD19 antibodies, and other new drugs
- Strategies for utilizing Ki67 and multigene assays as a window of opportunity in the treatment of HR+/HER2– early breast cancer in clinical practice